Overview

Study to Assess the Efficacy and Safety of VX-210 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

Status:
Terminated
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of VX-210 in subjects with Acute Traumatic Cervical Spinal Cord Injury. Secondary objectives include the specific evaluation of the effects of VX-210 on neurological recovery and daily function after spinal cord injury.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Vertex Pharmaceuticals Incorporated